INSIST! Myeloproliferative Neoplasms
April 2026
Biomarker testing can help your healthcare team determine the best care and treatment plan for you. The goal of INSIST! Myeloproliferative Neoplasms (MPNs) is to educate and empower patients and care partners to speak up and insist on better care.
Program topics include:
Personalize Your Experience!
Create an account to save items and receive information curated just for you.
Understanding MPNs and Testing
MPNs Explained: Key Tests at Diagnosis and Beyond
April 20, 2026
Self-Advocacy | Why In-Depth Cancer Testing Is Essential
December 5, 2025
Molecular Testing and Hereditary Testing: What’s the Difference?
December 5, 2025
When Should Someone With Cancer Undergo Molecular Testing?
November 6, 2025
What Is Molecular Testing and Why Is It Necessary in Cancer Care?
November 6, 2025
How Do MPNs Progress From One Disease to the Next?
October 21, 2021
What Questions Should Patients Ask About MPN Test Results?
October 21, 2021
Which Tests Do You Need Following an MPN Diagnosis?
October 21, 2021
What Is Personalized Medicine for ET, PV & MF?
October 21, 2021
Have You Had These Essential Myelofibrosis Tests?
March 24, 2021
MPN Treatment Decisions
Expert Advice for Finding an MPN Clinical Trial
January 7, 2022
MPN Research and Optimism About Curative Therapies
October 21, 2021
What To Expect When Starting MPN Inhibitor Therapy
October 21, 2021
An Overview of ET, PV and MF Treatment Options
October 21, 2021
What Are the Benefits of MPN Inhibitor Treatment?
October 21, 2021
Patient Considerations That Impact MPN Treatment Decisions
October 21, 2021
Which MPN Treatment Is Right for You? What You Need to Know
September 21, 2021
How Does Inhibitor Therapy Work to Treat Myelofibrosis?
March 24, 2021
Which Gene Mutations Impact Myelofibrosis Treatment Options?
March 24, 2021
INSIST! MPNs Resources
INSIST! MPNs is brought to you by the Patient Empowerment Network. It is made possible through support from Bristol Myers Squibb, Foundation Medicine, Illumina, and generous donations from people like you.